List of Oncology Medication For

Blood Disorders

Hematologic diseases are disorders which primarily affect the blood and blood-forming organs. Hematologic diseases include rare genetic disorders, anemia, HIV, sickle cell disease and complications from chemotherapy or transfusions.

If Blood Disorders Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Selinexor Tablets

Multiple Myeloma, Lymphoma

selinexor tablets,
for oral use Initial U.S. Approval: 2019

Xpovio (selinexor) is a medication used for the treatment of patients with relapsed/refractory multiple myeloma or diffuse large B-cell lymphoma. It has been approved by the European Medicines Agency (EMA) under the brand name Nexpovio (selinexor).

Facts about selinexor tablets

Disease Indications-Lymphoma, Multiple Myeloma
Manufacturer-Karyopharm
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “selinexor tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

SOHONOS (palovarotene) capsules

Bone marrow, Blood Disorders

SOHONOS (palovarotene) capsules, for oral use Initial U.S. Approval: 2023

Sohonos (palovarotene) is a retinoid. It lowers the amount of new abnormal bone growth in people with fibrodysplasia ossificans progressiva (FOP) by blocking an important process involving bone morphogenetic proteins (BMPs).

Brand Name:	SOHONOS
Generic Name:	palovarotene
Strength:	Capsules: 1, 1.5, 2.5, 5, 10 mg
Manufacturer:	IPSEN Biopharmaceuticals, Inc
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “SOHONOS (palovarotene) capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for SOHONOS (palovarotene) capsules price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Soliris (eculizumab) Injection

Blood Disorders

Soliris (eculizumab) Injection

Eculizumab specifically is a complement inhibitor used for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis. It is also used for the treatment of patients with atypical hemolytic uremic syndrome (aHUS) to inhibit the complement-mediated thrombotic microangiopathy.

Brand Name:	SOLIRIS
Generic Name:	Eculizumab
Strength:	• 300 mg single-use vials containing 30 mL of 10 mg/ml.
Manufacturer:	Alexion Pharma, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import Soliris (eculizumab) Injection” based on the information you provide.

Tagraxofusp-erzs-Injection

Leukemia

tagraxofusp-erzs injection,
for intravenous use Initial U.S. Approval: 2018

Elzonris (tagraxofusp-erzs) is a medication used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older.

Facts about tagraxofusp-erzs-injection

Disease Indications -Leukemia
Manufacturer-Stemline Therapeutics
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “tagraxofusp-erzs-injection” based on the information you provide.

TALVEY (talquetamab-tgvs) Injection

Multiple Myeloma

Brand Name: TALVEY. Generic Name: (talquetamab-tgvs). TALVEY (talquetamab-tgvs) is used to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies.

TALVEY is an antibody that is used to treat a form of blood cancer called multiple myeloma. It is used to treat adult patients whose cancer came back after, or did not respond to, at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody to treat their multiple myeloma.

Brand Name:	TALVEY
Generic Name:	talquetamab-tgvs
Strength:	Injection 3 mg/1.5 mL (2 mg/mL) in a single-dose vial 40 mg/mL in a single-dose vial
Manufacturer:	Janssen Biotech, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “TALVEY (talquetamab-tgvs)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for TALVEY (talquetamab-tgvs) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

TECVAYLI (teclistamab-cqyv) injection

Multiple Myeloma, Blood Disorders

TECVAYLI (teclistamab-cqyv) injection, for subcutaneous use
Initial U.S. Approval: 2022

TECVAYLI is a prescription medicine to treat adults with multiple myeloma who: have already received at least 4 treatment regimens, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody to treat their multiple myeloma, and.

Brand Name:	TECVAYLI
Generic Name:	teclistamab-cqyv
Strength:	Injection • 30 mg/3 mL (10 mg/mL) in a single-dose vial • 153 mg/1.7 mL (90 mg/mL) in a single-dose vial
Manufacturer:	Janssen Biotech, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “TECVAYLI (teclistamab-cqyv) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for TECVAYLI (teclistamab-cqyv) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Thalidomide Capsules

Multiple Myeloma

thalidomide capsules
for oral use Initial U.S. Approval: 1998

THALOMID in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (MM). • THALOMID is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). THALOMID is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. THALOMID is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.

Facts about thalidomide capsules

Approval Date: 1998
Proprietary Name: On Request
Active Ingredient(s): thalidomide capsules
Dosage Forms And Strengths: Capsules: 50 mg, 100 mg, 150 mg and 200 mg
Current indications: multiple myeloma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “thalidomide capsules” based on the information you provide.

TIBSOVO (ivosidenib Tablets)

Leukemia, Bile Duct Cancer

Generic Name: ivosidenib Brand Name: TIBSOVO
TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).

TIBSOVO is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. If you have any questions about your illness, talk to your doctor.

Brand Name:	TIBSOVO
Generic Name:	ivosidenib
Strength:	Tablets: 250 mg (3
Manufacturer:	Servier Pharmaceuticals
Approved By:	EMA, USFDA

Source Details: Patient Information

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import TIBSOVO (ivosidenib Tablets) ” based on the information you provide.

ULTOMIRIS (ravulizumab-cwvz) Injection

Blood Disorders

ULTOMIRIS (ravulizumab-cwvz) injection , for intravenous use Initial U.S. Approval: 2018

ULTOMIRIS is a complement inhibitor indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) Injection: 300 mg/30 mL (10 mg/mL) in a single-dose vial contact Alexion Pharmaceuticals, Inc.
If you have any questions about your illness, talk to your doctor
Source Details: Patient Information

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ULTOMIRIS (ravulizumab-cwvz) Injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

VANFLYTA (quizartinib) Tablets

Leukemia

Brand Name: VANFLYTA. Generic Name: (quizartinib). VANFLYTA (quizartinib) is used to use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria.

VANFLYTA is a kinase inhibitor (a kinase is a type of protein that regulates the function of cells in your body) that is used in combination with certain chemotherapy medicines and alone as maintenance therapy to treat adults with newly diagnosed acute myeloid leukemia (AML) with a specific mutation called FLT3 internal tandem duplication (FLT3-ITD) mutation. VANFLYTA is not indicated for use alone as maintenance therapy following a stem cell transplantation (bone marrow transplant).

Brand Name:	VANFLYTA
Generic Name:	quizartinib
Strength:	Tablets: 17.7 mg or 26.5 mg.
Manufacturer:	Daiichi Sankyo, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “VANFLYTA (quizartinib)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for VANFLYTA (quizartinib) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Blood Disorders

selinexor tablets, for oral use Initial U.S. Approval: 2019

Access the best support services globally

SOHONOS (palovarotene) capsules, for oral use Initial U.S. Approval: 2023

Soliris (eculizumab) Injection

Access the best support services globally

tagraxofusp-erzs injection, for intravenous use Initial U.S. Approval: 2018

Access the best support services globally

Brand Name: TALVEY. Generic Name: (talquetamab-tgvs). TALVEY (talquetamab-tgvs) is used to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies.

TECVAYLI (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 2022

thalidomide capsules for oral use Initial U.S. Approval: 1998

Facts about thalidomide capsules

Access the best support services globally

Generic Name: ivosidenib Brand Name: TIBSOVO TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).

Access Patient Name Basis Treatment

ULTOMIRIS (ravulizumab-cwvz) injection , for intravenous use Initial U.S. Approval: 2018

Access Patient Name Basis Treatment

Brand Name: VANFLYTA. Generic Name: (quizartinib). VANFLYTA (quizartinib) is used to use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria.

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

selinexor tablets,
for oral use Initial U.S. Approval: 2019

tagraxofusp-erzs injection,
for intravenous use Initial U.S. Approval: 2018

TECVAYLI (teclistamab-cqyv) injection, for subcutaneous use
Initial U.S. Approval: 2022

thalidomide capsules
for oral use Initial U.S. Approval: 1998

Generic Name: ivosidenib Brand Name: TIBSOVO
TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).